Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Buprenorphine/naloxone sublingual tablets
DRUG
2 trials
Sponsors
Orexo AB
, University of Vermont
Conditions
Opiate Dependence
Opioid-Related Disorders
Opioid-use Disorder
Phase 2
Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation
NCT03420313
University of Vermont
Opioid-use Disorder
Start: 2018-03-01
End: 2021-07-31
Target: 100
Updated: 2019-05-03
Phase 3
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
Completed
NCT01848054
Orexo AB
Opiate Dependence, Opioid-Related Disorders
Start: 2013-06-30
End: 2014-01-31
Updated: 2017-05-10
Related Papers
Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings
JAMA Network Open
2023-09-27
1 citations